Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

RSS icon
Thumbnail

Mishandled patient record drop off costs Parkview Health System $800,000

Indiana and Ohio non-profit Parkview Health System has reached a deal with the U.S. Department of Health and Human Services Office for Civil Rights (OCR) to settle potential violations of the Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy Rule that occurred when boxes of medical records were delivered to the home of a retiring doctor when she was not there.

FDA pilot program surveys EHR, claims data to monitor drug safety

FDA’s pilot program for the agency’s Sentinel System—dubbed Mini-Sentinel—is utilizing EHR data in combination with claims information to better monitor the safety of FDA-regulated products.

Thumbnail

Merger to create $3.8 billion Michigan healthcare organization moves forward

The three individual boards of Southeast Michigan’s Beaumont Health System, Botsford Health Care and Oakwood Healthcare unanimously approved a merger plan and the three healthcare systems’ leaders signed the definitive merger agreement this week.

Thumbnail

eCQMs & CDS: Two Sides of the Same Coin

Electronic clinical quality measures (eCQMs) and clinical decision support (CDS) share many similarities and common requirements, all with the goal of improving healthcare quality.

Thumbnail

Data Drives Better PCMH Outcomes: A Case Study of Strategic Analytics in Colorado Springs

Optum

In healthcare today, managing the health of patients and practices is all about managing risk. Adding value-driven, population-focused strategic analytics makes the process a lot less risky. Colorado Springs Health Partners (CSHP) is proof positive that analytics and clinical intelligence work for patients and providers.

Thumbnail

Slings, Arrows & a Few Good Allies

Can the Center for Medicare and Medicaid Innovation survive the political crossfire in which it finds itself caught?

HIMSS Analytics Announces Siemens as Certified Educator of the DELTA-Powered Analytics Assessment

CHICAGO (June 23, 2014) – HIMSS Analytics today named Siemens Healthcare a Certified Educator of the DELTA PoweredTM Analytics Assessment.

NextGen Healthcare and 3M Partner to Offer Industry-Wide ICD-10 Education Program

HORSHAM, Pa.--NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, announced today it has teamed with 3M Health Information Systems to offer 3M’s robust, web-based ICD-10 Education Program industry wide. The agreement strengthens the arsenal of resources NextGen Healthcare makes available to aid both clients and non-clients as they successfully transition to ICD-10.

Displaying 6993 - 7000 of 8455

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.